What BodeVet does

BodeVet, Inc. is a Rockville, Maryland-based veterinary biotechnology company founded in 2017 and operating as a subsidiary of Cellphire. The company develops and commercializes blood products for veterinary transfusion medicine, addressing unmet needs in companion and exotic animal care. Its core technology is proprietary trehalose-based lyophilization, which enables the production of shelf-stable, freeze-dried platelet and plasma products that do not require continuous refrigeration.

The flagship product, StablePlate RX, is positioned as the world's first injectable freeze-dried platelet product for canines and serves as a shelf-stable hemostatic agent for trauma, thrombocytopenia, ITP, DIC, and other bleeding conditions. The portfolio has expanded to include StablePlas (lyophilized canine plasma), DMSO cryopreserved platelets, fresh frozen plasma in multiple volumes, DEA 1.1 positive and negative packed red blood cells, stored whole blood, blood collection bag systems, and diagnostic test kits (Alvedia DEA 1 and DMS crossmatch). Manufacturing is conducted under cGMP with socially responsible sourcing, and the company has run or initiated clinical studies, including the 1-2017-K9 multicenter canine study and a U.S. Army-funded (USAMRAA) canine polytrauma trial awarded in 2020.

BodeVet operates a B2B go-to-market model, selling products through an authenticated online store (Shopify-hosted) to veterinary hospitals, emergency and specialty clinics, zoos, and equine practices. Distribution is supplemented by direct veterinary distributor relationships for supplies. Marketing relies heavily on industry conferences (IVECCS, ACVIM), research publications, and clinician testimonials. The company has secured non-dilutive funding through a $1.7M USAMRAA contract and a grant from the International Elephant Foundation for EEHV treatment development in partnership with the Smithsonian Global Health Program.

Name

BodeVet

Legal name

BodeVet, Inc.

Website

https://bodevet.com

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

1–10 employees

Short description

BodeVet is a Rockville, Maryland veterinary biotech company and Cellphire subsidiary that develops and sells shelf-stable, lyophilized platelet and plasma blood products to veterinary hospitals, specialty clinics, zoos, and equine practices.

Ownership category

akta.pro rank

Product category

Veterinary Blood Products and Transfusion Medicine

NAICS

Blood and Organ Banks (621991)

SIC

Biological Products, (No Disgnostic Substances) (2836)

akta.pro primary industry

Platelet-Rich Plasma (PRP) & Blood-Derived Orthobiologics (HLAMANAB)

akta.pro secondary industry

IV Therapy, Infusion & Fluid Management (Pumps, Catheters, Fluid Sets) (HLAMAFAG)

Keywords

• Veterinary blood products
• Lyophilized platelets
• Transfusion medicine
• Veterinary pharmaceuticals
• Canine hemostatic agents

Headquarters

HQ city

Rockville

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Technology or R&D, Marketing or Sales, Supply Chain, Personnel

Revenue model

1. Veterinary Blood Products Sales: BodeVet sells blood products including lyophilized platelets, fresh frozen plasma, packed red blood cells, and cryopreserved platelets directly to veterinary hospitals and clinics through their online store.
2. Blood Banking Supplies: Sale of blood banking supplies including collection bags, testing kits, and dry ice packaging for frozen products.
3. Veterinary Equipment and Testing Kits: Sale of DEA 1 blood type test kits, crossmatch test kits, and other blood banking equipment to veterinary practices.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels5 records

Core offering

BodeVet develops and sells shelf-stable lyophilized (freeze-dried) blood products for veterinary transfusion medicine, including the world's first injectable freeze-dried platelet product for canines (StablePlate RX). The company also supplies fresh frozen plasma, packed red blood cells, cryopreserved platelets, blood banking supplies, and diagnostic test kits to veterinary hospitals and clinics.

Product overview

BodeVet is a veterinary transfusion medicine company offering a portfolio of blood products and supplies for companion and exotic animals. The core product line centers on StablePlate RX, the world's first injectable freeze-dried platelet product for canines, which provides shelf-stable hemostatic coverage. Additional offerings include fresh frozen plasma in multiple volumes (240ml, 120ml, 60ml), packed red blood cells (DEA 1.1 positive and negative variants in 250ml and 125ml volumes), stored whole blood, cryopreserved platelets, blood collection systems (single, triple, and quadruple bag systems with ADSOL), blood typing test kits (Alvedia DEA 1), crossmatch test kits, and dry ice packaging for product shipping.

Differentiator

Problem solved

Functional benefit

Brands

• StablePlate RX: Lyophilized activated platelets for canines - shelf stable hemostatic agent derived from freeze-dried platelets
• StablePlas
• Thrombosomes

Products and services

• StablePlate RX Canine (8ml) Lyophilized (freeze-dried) activated canine platelets for veterinary transfusion medicine, providing a shelf-stable hemostatic agent for controlling life-threatening hemorrhage secondary to thrombocytopenia. Sold to veterinary hospitals and specialty clinics.
• StablePlate RX Canine (16ml) Larger volume lyophilized activated canine platelets for veterinary transfusion medicine, providing shelf-stable hemostatic coverage for bleeding control. Sold to veterinary hospitals.
• StablePlas Canine (Lyophilized Canine Plasma) Lyophilized canine plasma product for use in trauma resuscitation alongside StablePlate RX, used for hemodynamic stabilization following trauma. Sold to veterinary hospitals and clinics.
• Canine Packed Red Blood Cells (DEA 1.1 positive and negative, 250ml and 125ml) Packed red blood cells for canine transfusion in multiple volumes and blood type variants for veterinary transfusion support. Sold to veterinary practices.
• Canine Stored Whole Blood (450ml and 225ml) Stored whole blood for canine transfusion, DEA 1.1 negative, available in two volumes. Sold to veterinary hospitals.
• Canine Fresh Frozen Plasma (240ml, 120ml, 60ml) Fresh frozen plasma for canine transfusion in multiple volumes, plasma antibody negative. Sold to veterinary practices.
• DMSO Cryopreserved Platelets Cryopreserved platelets using DMSO, leukoreduced, containing 1.5 x 10^10 platelets. Sold to veterinary hospitals.
• Blood Collection Bag Systems (Quadruple, Triple, Single with ADSOL) Blood collection systems with ADSOL, 500ml draw capacity, for veterinary blood banking operations. Sold to veterinary practices.
• Alvedia DEA 1 Blood Type Test Kits Blood type test kits for canine DEA 1 blood type identification, available in individual and box-of-20 formats. Sold to veterinary practices.
• DMS Rapid Vet H Crossmatch Test Kit Crossmatch test kit for veterinary blood compatibility testing, box of 3 tests. Sold to veterinary practices.
• Dry Ice Packaging Dry ice packaging for shipping frozen blood products. Sold to veterinary customers.

Quantifiable outcome

• Wounds treated with multiple doses of VEGF and a single dose of freeze-dried platelets reached 90% closure faster than wounds left untreated
• +3 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Six partnerships are on record, tiered core, major and minor.

• U.S. Army Medical Research Acquisition Activity (USAMRAA)coreStrategic or Co-development Partner · 3 June 2020U.S. Army awarded BodeVet a 2-year, $1.7 million contract to conduct a clinical trial in canine polytrauma patients evaluating StablePlate RX (lyophilized platelets) and StablePlas (lyophilized plasma) for hemodynamic stabilization following trauma.
• Cellphire (Parent Company)coreStrategic or Co-development Partner · 20 July 2017Cellphire is the parent biotechnology company of BodeVet, specializing in human platelet-derived hemostatic products. The innovative treatment for elephants builds off cutting-edge research in human platelet-products from Cellphire.
• Smithsonian Global Health ProgrammajorStrategic or Co-development Partner · 20 July 2017BodeVet works with the Smithsonian Institute to develop lyophilized platelet products for elephants affected by Elephant Endotheliotropic Herpesvirus (EEHV). The Smithsonian provides elephant health expertise and collaboration on clinical trials.
• Ringling Bros. Center for Elephant ConservationminorStrategic or Co-development Partner · 20 July 2017Partner in the EEHV treatment development program, contributing elephant health expertise and hosting blood collection from Asian elephants.
• Fort Worth ZoominorStrategic or Co-development Partner · 20 July 2017Zoological partner providing elephant health expertise and participating in the EEHV treatment development program.
• Houston ZoominorStrategic or Co-development Partner · 20 July 2017Zoological partner contributing to the EEHV treatment development program with elephant health expertise.

Scale indicators3 records

Recent moves1 record

Expansion highlights6 records

Broad incumbents

• Zoetis: Largest pure-play animal health company globally, offering a broad portfolio of pharmaceuticals, diagnostics, and biologicals. While not focused on transfusion medicine specifically, Zoetis has the scale, distribution, and R&D resources to enter veterinary blood products if the category proves attractive.
• IDEXX Laboratories: Leading veterinary diagnostics company whose blood typing and crossmatch test kit offerings overlap with BodeVet's diagnostic supplies business. IDEXX's established veterinary distribution network and clinical relationships make it a relevant benchmark for channel reach.

Emerging players

• VetStem Biopharma: Veterinary regenerative medicine company offering autologous stem cell and platelet therapies for companion animals and horses. Competes with BodeVet in the regenerative orthobiologics space, particularly in equine platelet lysate applications.
• MediVet Biologics: Veterinary regenerative medicine company providing stem cell and PRP kits for in-clinic use. Competes in adjacent regenerative therapy categories and targets the same emergency and specialty veterinary hospitals as BodeVet.
• Ardent Animal Health: Provider of regenerative veterinary medicine including platelet-rich plasma (PRP) and stem cell therapies. Overlaps with BodeVet's regenerative/orthobiologics positioning, particularly for equine and small animal musculoskeletal applications.

Direct peers

• HemoPet / HemoSolutions: Veterinary blood bank and blood product supplier focused on canine transfusion medicine. Operates a similar B2B model supplying veterinary hospitals with conventional blood components, directly competing with BodeVet's fresh frozen plasma and packed red blood cell SKUs.
• Animal Blood Resources International (ABRI): Veterinary blood bank supplying canine and feline blood products (packed red cells, plasma, whole blood) to veterinary practices. ABRI competes head-to-head with BodeVet's traditional (non-lyophilized) blood product lines and serves the same veterinary hospital customer base.
• Cellphire: BodeVet's parent company develops Thrombosomes, a trehalose-stabilized freeze-dried human platelet product. Cellphire shares the same core lyophilization and trehalose stabilization IP with BodeVet, making it the most direct technological peer despite operating in human rather than veterinary medicine.

Others

• Covetrus: Major veterinary distribution company supplying products and supplies to veterinary practices. Relevant as a potential channel partner for BodeVet's products and as the incumbent in veterinary supply logistics.
• Patterson Veterinary Supply: Leading U.S. veterinary distributor serving companion animal practices. Functions as a potential distribution channel for BodeVet's blood products and supplies into the broader veterinary hospital market.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BodeVet